This prescription-based tablet formulation, as detailed in image_0a50a1.png, contains the active ingredients Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP. Available in a 10 x 15 tablet pack size, it is professionally intended for prescription-based diabetes management as advised by a doctor. The product is highly suitable for anti-diabetic product listings targeted toward clinics, pharmacies, hospitals, and commercial distributors. Patients must use this medication only as directed by a registered healthcare professional, taking it precisely at the prescribed time and dose. Finally, individuals should not stop, repeat, or change the dose without receiving explicit medical advice.